Olaris aims to fundamentally change how diseases are diagnosed and treated. With their pioneering metabolomics platform and machine learning algorithms, they produce personalized “Biomarkers of Response” (BoR) to readily differentiate drug responders (R) from non-responders (NR).

Biotechnology

Olaris

Elizabeth O'Day

Prof Dr Dirk Kuypers

Tom Burke

Jifang Zhao

Masoumeh Dorrani

Kari Boardman

Russell Herndon

Alessia Trimigno

Charles Sang

Chen Dong

Daniel Geffken

Monty Kothiwale

Scientific Research Team

Leadership Team

Finance and Business Management Team

Teams at Olaris

Scientific Research Team

Leadership Team

Finance and Business Management Team